High nuclear poly‐(ADP‐ribose)‐polymerase expression is prognostic of improved survival in pancreatic cancer
- 2 March 2012
- journal article
- Published by Wiley in Histopathology
- Vol. 61 (3) , 409-416
Abstract
Klauschen F, von Winterfeld M, Stenzinger A, Sinn B V, Budczies J, Kamphues C, Bahra M, Wittschieber D, Weichert W, Striefler J, Riess H, Dietel M & Denkert C (2012) Histopathology 61, 409–416High nuclear poly‐(ADP‐ribose)‐polymerase expression is prognostic of improved survival in pancreatic cancerAims: Poly‐(ADP‐ribose)‐polymerases (PARPs) act as post‐translational modifiers of proteins that are mainly involved in the DNA repair machinery, and have recently been shown to be predictive of pathologically complete remission after chemotherapy in breast cancer. In the pancreas, PARP expression has so far only been studied in inflammatory conditions. Therefore, in this study, we investigated the relevance of PARP in pancreatic cancer.Methods and results: Cytoplasmic and nuclear PARP expression was assessed by immunohistochemistry in a population‐based cohort of 178 adenocarcinomas of the pancreas and correlated with clinicopathological parameters. We found that low‐level nuclear expression of PARP is associated with a poor prognosis (median survival 9.6 versus 14.5 months, P = 0.004).Conclusions: Our analysis shows that nuclear PARP is an independent prognostic marker with respect to standard clinicopathological parameters. These results suggest that PARP should be further explored as a predictive factor with respect to conventional chemotherapy and concepts of PARP inhibitor therapy in pancreatic cancer.Keywords
This publication has 32 references indexed in Scilit:
- Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancerBritish Journal of Surgery, 2011
- Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancerBritish Journal of Cancer, 2011
- Epigenetics: poly(ADP‐ribosyl)ation of PARP‐1 regulates genomic methylation patternsThe FASEB Journal, 2008
- Poly(ADP-ribose): novel functions for an old moleculeNature Reviews Molecular Cell Biology, 2006
- The PARP superfamilyBioEssays, 2004
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- PARP-1, a determinant of cell survival in response to DNA damageExperimental Hematology, 2003
- PARP Goes TranscriptionCell, 2003
- Long‐term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25‐Year ExperienceWorld Journal of Surgery, 2003
- Role of PARP Under Stress Conditions: Cell Death or Protection?Neurochemical Research, 2003